Samuel Shangwu Wu, PhD, discusses his recent work evaluating TMRCP as an effective endpoint for future T1D trials.
Samuel Shangwu Wu, PhD
Advertisement
Samuel Shangwu Wu, PhD, is a professor and deputy director of the Health Informatics Institute at the University of South Florida.
Articles by Samuel Shangwu Wu, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
What to Expect at the 2026 APAPP National Conference
2
Antibiotic Stewardship in Dermatology: A Call to Prescribe Less
3
The Cost of Delay: How Prior Authorization Is Impacting Dermatology
4
When Abdominal Pain Is Actually a Food Allergy: A GI Workup
5